Interleukin (IL)-15 in combination with IL-2, fms-like tyrosine kinase-3 ligand and anti-CD3 significantly enhances umbilical cord blood natural killer (NK) cell and NK-cell subset expansion and NK function

By Satwani Prakash   van de Ven Carmella   Ayello Janet   Cairo Dustin   Simpson Lynn L.   Baxi Laxmi   Cairo Mitchell S.  

Cytotherapy, Vol. 13, Iss. 6, 2011-07 ,pp. : 730-738

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Functional characterization of interleukin-15 gene transduction into the human natural killer cell line NKL

By Jiang W.   Zhang J.   Tian Z.  

Cytotherapy, Vol. 10, Iss. 3, 2008-04 ,pp. : 265-274

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Implication of maternal-cell contamination in the clinical banking of umbilical cord blood

By Tsang KS   Wong APY   Cheung MS   Tang SH   Leung Y   Li CK   Lau TT   Ng MHL   Yuen PMP  

Cytotherapy, Vol. 4, Iss. 4, 2002-07 ,pp. : 375-383

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Human Umbilical Cord Blood as an Emerging Stem Cell Therapy for Diabetes Mellitus

By  

Current Stem Cell Research & Therapy, Vol. 5, Iss. 4, 2010-12 ,pp. : 356-361

Bentham Science Publishers

Access to resources Recommend Favorite

New developments with umbilical cord blood

By Bhakta S.   Laughlin Mj  

Cytotherapy, Vol. 10, Iss. 2, 2008-01 ,pp. : 105-107

Ashgate Publishing Ltd

Access to resources Recommend Favorite